After a pilot program last year, the company is launching its Noom Med option – available in 32 states – that will include prescriptions for Ozempic, Wegovy, Mounjaro and other GLP-1 obesity drugs for about $120 a month.

As AI continues to develop and evolve, HR professionals must stay up to date with the changing technology.

The outbreak period will end on July 10, 2023 - 60 days after the COVID national emergencies ended - so employers need to decide whether or not to revert to normal cost-sharing for coverage of COVID-19 tests and vaccines.

This episode of the #RockstarsRocking podcast features Broker of the Year finalist Jenni Bickerstaff, Senior Partner/ SVP of Employee Benefits at AHT Insurance of out of the Northern Virginia area.